MRSA Screening Before SuperPATH Hip Replacement

A positive MRSA screening result before hip replacement doesn't necessarily mean you're sick or that surgery must be canceled. The test helps your care team identify bacteria that could increase infection risk and plan any needed prevention steps.

If you're preparing for SuperPATH hip replacement, MRSA screening may be part of your preoperative preparation . Understanding the test starts with knowing what it looks for and how the results may affect your care.

Key Takeaways

• MRSA screening checks for bacterial carriage, which differs from an active infection.
• A positive result may lead to prescribed nasal treatment, antiseptic washes, or changes to surgical antibiotics.
• Screening schedules and treatment instructions vary, so follow your own surgical team's plan.

Why MRSA Screening Matters Before Hip Replacement

MRSA stands for methicillin-resistant Staphylococcus aureus. This type of staph bacteria resists several commonly used antibiotics, although treatments are available.

The American Academy of Orthopaedic Surgeons (AAOS) recommends screening for MRSA and methicillin-sensitive Staphylococcus aureus , or MSSA, before surgery, particularly joint replacement. Both types can cause infections.

Protecting the artificial joint

Hip replacement places artificial components inside your body. If bacteria reach those components, an infection can be difficult to treat. It may require prolonged antibiotics or additional surgery.

Screening helps identify people who carry staph bacteria before an incision creates an entry point. The team can then consider measures to reduce bacterial carriage and choose appropriate surgical antibiotics.

This check belongs within a broader health review. The SuperPATH preoperative clearance guide also covers medical conditions, medication planning, and new illnesses that may affect readiness for surgery.

SuperPATH still requires infection prevention

SuperPATH is a tissue-sparing approach to total hip replacement. It aims to limit disruption of muscles and other soft tissues around the hip.

However, a smaller access point doesn't remove infection risk. The operation still involves an incision, bone preparation, and implants.

MRSA prevention follows the same basic principles used for other hip replacement approaches. Your surgeon and surgical facility determine which screening and prevention measures apply to you.

What Happens During MRSA Screening

Screening usually involves collecting a sample with a swab. It checks for bacteria you may carry even when you feel well.

The swab and laboratory test

A clinician commonly swabs inside your nostrils because staph bacteria can live in the nose. The collection is brief and may feel uncomfortable, but it doesn't usually involve a needle.

Some facilities also sample other sites according to their policies or your history. There isn't one required set of swab locations for every patient.

Laboratories may use a culture, which grows bacteria, or a molecular test such as PCR, which detects bacterial genetic material. Result timing differs by test and facility, so ask when you should expect an answer.

Timing and result follow-up

Arrange screening early enough for the team to receive results and complete any prescribed treatment before surgery. Some decolonization courses last five days, but there's no universal screening deadline.

Ask who will review your result and contact you if treatment is needed. If your procedure is approaching and you haven't heard back, call rather than assuming the test was negative.

Also ask whether the test checks for both MRSA and MSSA. Either result may influence the prevention plan.

What a Positive MRSA Screen Means

A positive result identifies MRSA at the sampled site. It doesn't, by itself, diagnose an infection in your hip, bloodstream, or another part of your body.

Carriage differs from active infection

Colonization , also called carriage, means bacteria live on or in your body without causing illness. You can carry MRSA without pain, fever, or a visible skin problem.

An active infection means bacteria are causing disease. Symptoms might include a painful skin sore, spreading redness, pus, or fever.

These situations require different decisions. Treatment to reduce nasal carriage isn't a substitute for evaluating an infected wound or another suspected infection. Tell your team about symptoms even if you already completed screening.

A positive result doesn't automatically postpone surgery

Your team may keep the scheduled date after arranging prevention measures. In other cases, the surgeon may recommend more evaluation, treatment, or a delay.

The decision depends on whether you have an active infection, your overall health, the planned treatment, and facility policy.

Ask what must happen before you can proceed. You should also know whether repeat testing is needed, since requirements differ among practices and surgical centers.

Treatment to Reduce Bacteria Before Surgery

Treatment for carriage is often called decolonization. Its goal is to reduce the amount of bacteria and lower infection risk, although it doesn't guarantee permanent clearance.

Prescribed nasal treatment

Mupirocin is an antibiotic ointment that clinicians may prescribe for use inside the nostrils. The Centers for Disease Control and Prevention (CDC) describes one orthopedic prevention option using nasal mupirocin twice daily for five days before surgery.

However, other protocols use different schedules. AAOS describes a three-times-daily, five-day regimen, so follow the instructions your team gives you rather than choosing between online schedules.

Some centers use a nasal iodine-based antiseptic shortly before surgery instead. These products aren't interchangeable with ordinary skin antiseptics.

Ask for the product name, application method, start date, and final dose timing in writing. If you miss a dose or develop irritation, contact the team for instructions.

Antiseptic body washing

Your team may also recommend chlorhexidine, often shortened to CHG, as a body wash or wipes. CDC guidance includes daily CHG washing or wipes for up to five days before certain high-risk surgeries.

Follow the product label and your facility's directions carefully. Chlorhexidine products have restrictions on where they can be applied, including avoiding contact with eyes and ears.

Tell your team about previous reactions to chlorhexidine, mupirocin, or other antiseptics before starting treatment. Don't add extra applications, combine products, or substitute leftover medication.

Completing the prescribed course matters, but additional treatment isn't automatically more effective or safer.

How Screening Can Affect Surgical Antibiotics

Patients generally receive preventive antibiotics around hip replacement surgery. These medicines differ from nasal decolonization treatment.

Cefazolin is commonly used when appropriate. For known MRSA carriers, the team may consider vancomycin alongside the usual procedure-appropriate antibiotic. Vancomycin doesn't automatically replace standard coverage for MSSA when the patient can receive a suitable beta-lactam antibiotic.

Current infection-prevention guidance doesn't recommend routine vancomycin for every patient. Your result, allergy history, kidney function, and facility protocol help guide the choice.

Antibiotic timing also matters. Standard preventive agents generally start within 60 minutes before the incision, while vancomycin may start within 120 minutes because its infusion takes longer.

Your surgical and anesthesia teams manage these details. Tell them about past antibiotic reactions and what happened during each reaction. Don't start leftover antibiotics on your own or assume nasal treatment removes the need for preventive antibiotics during surgery.

Preparing for Screening and Recovery

Bring information about previous MRSA tests, staph infections, recent antibiotics, hospital stays, and any current wounds. A past positive result deserves mention even if it was years ago.

Also provide a complete medication and allergy list. Diabetes, corticosteroid use, and other conditions or medicines can affect infection risk and surgical planning. Never stop prescribed treatment without instructions.

Before surgery, report a new fever, draining sore, rash, or other illness promptly. A screening result can't replace an examination of a new problem.

After surgery, follow your dressing and wound-care instructions. The guidance on SuperPATH incision care at home explains why dressing type and closure method affect your routine.

Know which changes require a call. Increasing drainage, spreading redness, worsening pain, or fever warrant attention. Reviewing the warning signs of hip replacement infection can help you describe changes clearly to your team.

Questions to Ask Your Orthopedic Team

When choosing an orthopedic surgeon, ask how the practice coordinates infection screening, treatment instructions, and result follow-up. You should understand who is responsible for each step.

At your consultation with Dr. Peter Ameglio in Fort Myers, bring your infection history and ask which preparation steps apply to you.

Useful questions include:

• Do I need MRSA and MSSA screening, and when should I complete it?
• Who will contact me about the results, and what happens if the screen is positive?
• Which nasal product or body wash should I use, and what is the exact schedule?
• Will my result change the surgical antibiotics or require repeat testing?
• What could delay surgery, and who should I call about symptoms or missed treatment?

Write down the answers. If the surgeon's office and surgical facility give different instructions, ask them to clarify the plan before starting.

Frequently Asked Questions

Does a negative MRSA screen mean I can't develop an infection?

A negative result means the test didn't detect MRSA in the sample collected. It doesn't eliminate every infection risk.

Other bacteria, including MSSA, can cause surgical infections. Screening also reflects the sampled site and the time of testing.

Therefore, continue following all preparation and wound-care instructions after a negative result. Report new skin problems or illness before surgery, and contact the team about concerning incision changes afterward. Don't skip prescribed washes or other prevention steps because your screen was negative.

Do family members need MRSA testing too?

A positive preoperative screen doesn't automatically mean everyone in your household needs testing or treatment. Your care team can advise you based on your history and whether anyone has symptoms or repeated infections.

At home, wash your hands regularly and avoid sharing towels or razors. Anyone with a painful, draining skin sore should seek medical evaluation.

Don't share prescribed mupirocin or other treatment products. If a household member has a known MRSA infection, tell your surgical team before your procedure.

Conclusion

MRSA screening before SuperPATH hip replacement helps your team plan infection prevention. A positive result often means bacterial carriage, while an active infection requires a separate evaluation.

The most useful next step is a clear, individualized plan for testing, any prescribed treatment, and result follow-up. Knowing who to contact helps you address concerns before surgery rather than guessing about what a result means.